40 Hz Gamma Waves and Alzheimer's: MIT Research Explained

The Discovery That Changed Alzheimer's Research

In 2016, a team led by Dr. Li-Huei Tsai at MIT's Picower Institute for Learning and Memory published a paper in Nature that sent shockwaves through the neuroscience community. They had discovered that exposing mice with Alzheimer's-like pathology to flickering light at precisely 40 Hz: 40 flashes per second, significantly reduced the levels of amyloid beta plaques in their brains.

Amyloid beta accumulation is one of the hallmark features of Alzheimer's disease. For decades, pharmaceutical companies have spent billions trying to develop drugs to clear these plaques, with limited success. The idea that a simple, non-invasive sensory stimulus could accomplish what expensive drugs had failed to do was extraordinary.

How 40 Hz Stimulation Works

The Gamma Connection

40 Hz falls in the gamma brainwave range (30-100 Hz), which is associated with higher cognitive functions including attention, memory, and consciousness. In healthy brains, gamma oscillations help synchronize neural activity across different brain regions, facilitating information processing and memory formation.

In Alzheimer's disease, gamma oscillations are disrupted. Neural circuits lose their ability to synchronize at gamma frequencies, and this disruption correlates with cognitive decline. The MIT team hypothesized that artificially restoring gamma oscillations might counteract some of the disease's effects.

The GENUS Protocol

The MIT lab developed a protocol they call GENUS (Gamma ENtrainment Using Sensory stimuli). The approach uses precisely timed sensory stimuli, flickering light, clicking sounds, or both, at 40 Hz to entrain the brain's gamma oscillations.

Key findings from the mouse studies include:

• **Amyloid reduction**: One hour of daily 40 Hz light exposure reduced amyloid beta levels by 40-50% in the visual cortex of Alzheimer's model mice (Iaccarino et al., 2016, *Nature*)
• **Combined sensory stimulation**: Adding 40 Hz auditory stimulation to the light exposure expanded the effect beyond the visual cortex to the auditory cortex and hippocampus, a critical region for memory (Martorell et al., 2019, *Cell*)
• **Tau reduction**: A follow-up study showed that the stimulation also reduced tau tangles, the other major pathological hallmark of Alzheimer's (Adaikkan et al., 2019)
• **Microglial activation**: The 40 Hz stimulation appeared to activate the brain's immune cells (microglia), which then cleared amyloid plaques through a process called phagocytosis
• **Preserved neurons**: Mice receiving chronic 40 Hz stimulation showed less neuronal death and synapse loss compared to untreated mice

From Mice to Humans

The critical question is whether these results translate to humans. Several human trials have been conducted or are underway:

Early Human Studies

A 2021 pilot study from the MIT group tested 40 Hz light and sound stimulation in a small group of people with mild Alzheimer's. After three months of daily sessions, participants showed:

• Reduced brain atrophy compared to the control group (measured by MRI)
• Improved functional connectivity between brain regions
• Better performance on face-name association tests (a memory task that Alzheimer's patients typically struggle with)

The sample size was small (about 15 participants), but the results were promising enough to launch larger trials.

The Cognito Therapeutics Trial

Cognito Therapeutics, a company spun out of the MIT research, has conducted a Phase II clinical trial using a wearable device that delivers combined 40 Hz light and sound stimulation. Results presented at the 2022 Clinical Trials on Alzheimer's Disease (CTAD) conference showed that participants using the device for six months experienced significantly less cognitive decline than the placebo group on standard Alzheimer's assessment scales.

The FDA granted Cognito's device Breakthrough Device designation, which expedites the review process for technologies addressing serious conditions with unmet needs.

Ongoing Research

As of early 2026, multiple larger trials are underway worldwide. Research groups in South Korea, Australia, and Europe are conducting independent studies on 40 Hz stimulation for various forms of neurodegeneration, including Parkinson's disease and frontotemporal dementia.

What About Binaural Beats at 40 Hz?

This is a question many people ask: can you get the same benefits from 40 Hz binaural beats?

The honest answer is that we do not know for certain. The MIT research used direct sensory stimulation, flickering lights and clicking sounds at precisely 40 Hz. Binaural beats work differently: they present two frequencies (for example, 200 Hz and 240 Hz) and rely on the brain to generate the 40 Hz perception internally.

There are reasons to think binaural beats might produce some of the same effects:

• EEG studies confirm that 40 Hz binaural beats increase gamma oscillations in the brain
• The entrainment involves auditory processing pathways similar to those activated by direct 40 Hz clicks
• Some of the human studies have used auditory stimulation as part of the protocol

However, the entrainment from binaural beats may be less robust than direct 40 Hz pulse trains. The MIT protocol uses very precise timing with sharp onset/offset patterns, while binaural beats produce a smoother, more sinusoidal oscillation.

Research specifically comparing binaural beat gamma entrainment to pulsed stimulation for amyloid clearance has not been published yet. Until such studies exist, we cannot make definitive claims.

What This Means for Brain Health

Even if the Alzheimer's-specific benefits require the precise clinical protocol, the broader implications for brain health are significant:

• **Gamma oscillations matter**: Maintaining healthy gamma activity throughout life may be protective against cognitive decline
• **Use it or lose it**: Regular cognitive engagement that promotes gamma activity (learning new skills, complex problem-solving, [meditation](/blog/binaural-beats-meditation-better-than-silence)) is supported by this research as neuroprotective
• **Sound-based brain stimulation is legitimate**: The MIT research validates the broader principle that auditory stimulation can meaningfully influence brain function, which is the same principle underlying binaural beats

Important Caveats

• **This is not a cure for Alzheimer's**: Even in the best mouse studies, 40 Hz stimulation slowed progression and reduced markers; it did not reverse the disease
• **Do not replace medical care**: If you or a loved one has been diagnosed with Alzheimer's or another neurodegenerative condition, work with qualified medical professionals. 40 Hz stimulation is a research intervention, not an approved treatment
• **Individual variation**: Not all participants in human studies responded equally, and the optimal protocol (duration, frequency of sessions, combination with other interventions) is still being refined

Try Gamma-Range Sessions

While the clinical research continues, you can explore 40 Hz gamma-range binaural beats for their well-established benefits on focus, attention, and cognitive performance. The Binaural offers sessions targeting gamma frequencies that may support overall brain health. Start a free focus session and experience gamma entrainment for yourself.